- This event has passed.
2025 BioNJ C-Suite Summit
October 30, 2025 @ 7:30 am – 2:30 pm
Life Sciences Leadership Through Uncertainties
Thursday, October 30, 2025 | 7:30 a.m.-2:30 p.m.
Bridgewater Marriott , 700 Commons Way, Bridgewater
Registration is $695 for BioNJ Members and $895 for Future Members
Biopharma leaders are navigating through a period of evolving dynamics marked by AI-driven acceleration in advancing breakthroughs in therapeutics and commercial capabilities against a backdrop of compressed product lifecycles, mounting macroeconomic headwinds and disruptions in geopolitical order.
Join BioNJ and industry leaders on October 30 to explore these converging forces, exchange proven resilience strategies and chart a course for sustaining innovation and growth in even the most unpredictable environments. With dedicated networking sessions built into the program — including opportunities to connect directly with speakers — this event is designed to foster meaningful dialogue and lasting connections among C-Suite leaders and industry innovators.
Liz Barrett
CEO
UroGen Pharma
Mark Campbell
CEO
Civia Health
Michael Cantor, M.D.
Vice President
Data Technology
& Innovation
Regeneron
Brian Curci
Associate Partner
Data & Agentic
AI Leader, Life Sciences
& Healthcare
IBM
Nick Downing, M.D.
Managing Director
Bain Capital Life Sciences
Marc Fogarty
Partner
EisnerAmper
Nick Garlow
Managing Director
Rational 360
Laurie Gery
Head, Business Development
& Licensing, Vaccines
Sanofi
Hisham Hamadeh
Senior Vice President
Global Head of Data
Digital & Artificial Intelligence
Genmab
Debbie Hart
President & CEO
BioNJ
Ashutosh Katiyar
Executive Director
Commercial Insights
& Analytics
Ophthalmology
Regeneron
Matthew B. Klein, M.D., M.S., F.A.C.S.
Chief Executive Officer
PTC Therapeutics
John Koufos
President
Cottage Four Strategic Solutions
David Kuninger, Ph.D.
Director, R&D
Thermo Fisher Scientific
Emer Leahy, Ph.D., MBA
President & CEO
PsychoGenics &
Chair, BioNJ
Evan Lippman
Executive Vice President
Business Development
Teva Pharmaceuticals
Clive Meanwell, M.D., Ph.D.
Chairman
Population Health Partners
Christine Ann Miller
CEO
Melinta Therapeutics
Chris Mortko, Ph.D., MBA
Vice President, Head Search &
Evaluation Business
Development & Licensing
Merck & Co.
Tim Opler
Managing Director
Global Healthcare Group
Stifel
Emilio Ragosa
Partner, Managing Partner, Short Hills, Global Co-Chair, Life Sciences and Healthcare Sector
DLA Piper
MaryAnne Rizk, Ph.D.
Head, Healthcare &
Life Sciences, AI
Amazon Web Services
Eduardo Schur
US Life Sciences
Commercial Strategy
and R&D Lead
EY
Nauman Shah
Global Head
Innovative Medicine
Business Development
Johnson & Johnson
Arda Ural, Ph.D.
Americas Life Sciences Leader
EY
Thank You To Our Sponsors
